Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jun 13, 2024 | Jun 14, 2024 | Legorreta Pablo G. Dir 10% | Buy | Prokidney Corp. | PROK | $2.42 | $55M | +50.00% |
Jun 28, 2023 | Jun 28, 2023 | Legorreta Pablo G. CEO COB 10% | Buy | Royalty Pharma Plc | RPRX | $29.51 | $4M | +3.34% |
Jun 12, 2023 | Jun 13, 2023 | Legorreta Pablo G. CEO COB 10% | Buy | Royalty Pharma Plc | RPRX | $32.89 | $3M | +2.42% |
May 24, 2023 | May 24, 2023 | Legorreta Pablo G. CEO COB 10% | Buy | Royalty Pharma Plc | RPRX | $32.25 | $5M | +4.07% |
May 16, 2023 | May 17, 2023 | Legorreta Pablo G. CEO COB 10% | Buy | Royalty Pharma Plc | RPRX | $33.38 | $8M | +6.36% |
Jan 31, 2022 | Feb 01, 2022 | Legorreta Pablo G. Dir 10% | Buy | Epizyme, Inc. | EPZM | $1.5 | $34M | +41.59% |
Jun 18, 2020 | Jun 23, 2020 | Legorreta Pablo G. CEO COB 10% | Buy | Royalty Pharma Plc | RPRX | $28 | $560,000 | +7.36% |